A rapid, simple questionnaire to assess gastrointestinal symptoms after oral ferrous sulphate supplementation
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Oral iron supplementation is often associated with rapid onset of gastrointestinal side-effects. The aim of this study was to develop and trial a short, simple questionnaire to capture these early side-effects and to determine which symptoms are more discriminating. METHODS: The study was a double-blind placebo-controlled randomized parallel trial with one week treatment followed by one week wash-out. Subjects were randomized into two treatment groups (n = 10/group) to receive either ferrous sulphate (200 mg capsules containing 65 mg of iron) or placebo, both to be taken at mealtimes twice daily during the treatment period. Subjects completed the questionnaires daily for 14 days. The questionnaire included gastrointestinal symptoms commonly reported to be associated with the oral intake of ferrous iron salts (i.e. nausea, vomiting, heartburn, abdominal pain, diarrhoea, and constipation). RESULTS: Seventy five per cent of participants reporting the presence of one or more symptoms in the first week of the study were in the ferrous sulphate group. In the second week of the study (i.e. wash-out), 67% of the participants reporting one or more symptom(s) were in the ferrous sulphate group. In the first week of the study (treatment) the number of symptoms reported by participants in the ferrous sulphate group (mean ± SEM = 6.7 ± 1.7) was significantly higher than that for participants in the placebo group (1.2 ± 0.5) (p = 0.01). In the second week of the study (wash-out) the number of symptoms reported by participants in the ferrous sulphate group (4.6 ± 2.0) appeared higher than for participants in the placebo group (1.0 ± 0.7) although this did not reach significance (p = 0.12). Events for which the gastrointestinal symptom questionnaire was most discriminatory between ferrous sulphate and placebo groups were: heartburn, abdominal pain and the presence of black stools (all p ≤ 0.03). CONCLUSIONS: A tool for the detection of commonly-occurring side effects should not require large study numbers to be effective. With just 10 subjects per group (iron or placebo), this simple questionnaire measures gastrointestinal side-effects associated with oral iron (ferrous sulphate) supplementation, and would be appropriate for use in intervention studies or clinical trials. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02146053 (21/05/2014).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
The epidemiology of global micronutrient deficiencies
Bailey, R. L., West Jr., K. P., & Black, R. E. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000371618 · Cited by 2,035
Sazawal, S., Black, R. E., Ramsan, M., Chwaya, H. M., Stoltzfus, R. J., Dutta, A., Dhingra, U., Kabole, I., Deb, S., Othman, M. K., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67962-2 · Cited by 981 · cited 1×
“One of the hurdles to eradicate this disorder has been the use of iron preparations, typically ferrous iron salts 65 mgFe 2–3 times daily [4], that risk significant gastrointestinal disturbances [5-10] and systemic infection [11-14].”
BackgroundZimmermann, M. B., Chassard, C., Rohner, F., N'Goran, E. K., Nindjin, C., Dostal, A., Utzinger, J., Ghattas, H., Lacroix, C., & Hurrell, R. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004564 · Cited by 520 · cited 2×
“Reasons for gastrointestinal disturbance are well described: even in subjects with IDA only about 20-30% of oral supplemented iron is absorbed, while the remainder transits through the gut lumen inducing (a) free radical mediated damage to the gut mucosa [9,24-26] and (b) undesirable changes to colonic microflora [27-…”
BackgroundViral infection and iron metabolism
Drakesmith, H., & Prentice, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1930 · Cited by 469
Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis
Werner, T., Wagner, S. J., Martínez, I., Walter, J., Chang, J.-S., Clavel, T., Kisling, S., Schuemann, K., & Haller, D. (2011) · Gut · doi:10.1136/gut.2010.216929 · Cited by 299 · cited 3×
“Reasons for gastrointestinal disturbance are well described: even in subjects with IDA only about 20-30% of oral supplemented iron is absorbed, while the remainder transits through the gut lumen inducing (a) free radical mediated damage to the gut mucosa [9,24-26] and (b) undesirable changes to colonic microflora [27-…”
BackgroundDeterminants of compliance with iron supplementation: Supplies, side effects, or psychology?
Galloway, R., & McGuire, J. (1994) · Social Science & Medicine · doi:10.1016/0277-9536(94)90135-x · Cited by 277
Kortman, G. A. M., Boleij, A., Swinkels, D. W., & Tjalsma, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029968 · Cited by 195 · cited 1×
“Furthermore, detrimental changes to the commensal microbiota have recently been reported with oral iron supplementation and may be partly responsible for the distal symptoms such as constipation and diarrhoea [27-29,56].”
BackgroundJerndal, P., Ringström, G., Agerforz, P., Karpefors, M., Akkermans, L. M., Bayati, A., & Simrén, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01493.x · Cited by 192
Determinants of compliance with iron supplementation among pregnant women in Senegal
Seck, B. C., & Jackson, R. T. (2008) · Public Health Nutrition · doi:10.1017/s1368980007000924 · Cited by 154 · cited 1×
“Gastrointestinal symptoms impact on the general wellbeing of individuals [30-37] and are known to affect compliance with oral iron therapy and, therefore, treatment efficacy [7,19,38-40].”
Background
Cited by
Tolkien, Z., Stecher, L., Mander, A. P., Pereira, D. I. A., & Powell, J. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117383 · Cited by 833
Self-citationUK guidelines on the management of iron deficiency in pregnancy
Pavord, S., Daru, J., Prasannan, N., Robinson, S., Stanworth, S., Girling, J., & on behalf of the BSH Committee (2020) · British Journal of Haematology · doi:10.1111/bjh.16221 · Cited by 418
Daily iron supplementation for improving anaemia, iron status and health in menstruating women
Low, M. S. Y., Speedy, J., Styles, C. E., De-Regil, L. M., & Pasricha, S.-R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009747.pub2 · Cited by 178
Metadata
- Authors
- Pereira, D. I., Couto Irving, S. S., Lomer, M. C., & Powell, J. J.
- Venue
- BMC Gastroenterology
- Published
- 2014-06-04
- Volume
- 14
- Issue
- 1
- Pages
- 103-103
- ISSN
- 1471-230X (ISSN-L)
- OpenAlex
- W2077046532
- Cited by
- 59
- References
- 13
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A rapid, simple questionnaire to assess gastrointestinal symptoms after oral ferrous sulphate supplementation. https://app.cochat.ai/papers/10.1186/1471-230x-14-103
- The paper
- Pereira, D. I., Couto Irving, S. S., Lomer, M. C., & Powell, J. J. (2014). A rapid, simple questionnaire to assess gastrointestinal symptoms after oral ferrous sulphate supplementation. BMC Gastroenterology. https://doi.org/10.1186/1471-230x-14-103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.